Targeted News Service

American Academy of Pediatrics: Research Analyzes Cost-Effectiveness of Two Medications to Prevent Respiratory Syncytial Virus in Infants
November 27, 2024

ITASCA, Illinois, Nov. 27 (TNSres) -- The American Academy of Pediatrics issued the following news release:

Two studies by the same team of health economists estimate the cost effectiveness of two products used to prevent respiratory syncytial virus (RSV) disease in infants: a maternal vaccination, RSVpreF, and a monoclonal antibody, nirsevimab, which is an immunization for infants.

The studies, "Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Sy . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form